AstraZeneca (AZN) has released an update.
AstraZeneca PLC has announced a 7% increase in its annual dividend for 2024, raising it to $3.10 per share, signaling the company’s confidence in its financial performance and future prospects. The consistent dividend policy aligns with AstraZeneca’s progressive approach and its commitment to shareholder returns, amidst various capital allocation considerations including recent acquisitions. The pharmaceutical giant, known for its contributions in Oncology, Rare Diseases, and other major therapeutic areas, maintains its regular dividend payout schedule with no alterations anticipated.
For further insights into AZN stock, check out TipRanks’ Stock Analysis page.
